This test detects variations in the SLCO1B1 gene. It identifies individuals with a specific drug transporter defect associated with statin-induced myopathy. It assists healthcare providers in selecting a statin that is less likely to cause this adverse event. Please be advised that Boston Heart Diagnostics policy states that practitioners are unable to order labs on themselves or their immediate family members.
.svg){kind=small}
.svg){kind=small}
On December 11th, join Dr. Terry Wahls in a 
